Screening Cardiovascular Patients for Aortic Aneurysms
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- AAA prevalence
研究概览
简要总结
Screening studies for Abdominal Aortic Aneurysms (AAA) in 65 to 79 years aged men, have shown a significant reduction in AAA related mortality. In addition, the cost-effectiveness of screening for AAA in men in the Netherlands has been demonstrated by using a Markov model. Screening might be even more (cost-) effective if targeted on high risk groups, such as patients with a particular cardiovascular disease with a known increased risk of having an AAA.
Project SCAN (Screening CardioVascular patients for Aortic aNeurysms) is a project focused on targeted AAA screening to proactively diagnose patients at high risk of having an aneurysm that eventually may rupture. This pilot project aims to study the value of a screening protocol in daily practice to detect AAA's in high risk patients.
详细描述
-
Offering PAD and CAD patients a non-invasive abdominal ultrasound after a careful process of shared-decision making
-
Recording data on aneurysm detection on all PAD and CAD patients screened:
-
General information (age, gender)
-
Medical history on CardioVascular risk factors (such as smoking history, hypertension, and other cardiovascular medical conditions - only information that is already recorded in the patient's medical history chart)
-
AAA - Yes/ No (Yes if ≥3 cm AAA)
-
If ≥3 cm aneurysm, record exact size and outcome in time (surveillance, treatment, no treatment)
-
If treated, record treatment type (EVAR or Open) and outcome
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 55 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •male and female patients
- •peripheral arterial disease (ankle brachial index < 0,90 and/or reduction of > 0.15 after exercise test) or a carotid stenosis (stenosis ≥ 50%)
- •age > 55 year
排除标准
- •Patients unfit for endovascular or open surgery (as judged by vascular surgeon)
- •Failure to master the dutch language
结局指标
主要结局
AAA prevalence
时间窗: 1 year
次要结局
未报告次要终点
研究者
Joep Teijink
MD, PhD, Vascular Surgeon
Catharina Ziekenhuis Eindhoven